The effects of photoactivated ciprofloxacin and bile acids on biofilms on bile duct catheters.

Biofilms bile acids catheters photoactivatable antibiotic

Journal

International journal of antimicrobial agents
ISSN: 1872-7913
Titre abrégé: Int J Antimicrob Agents
Pays: Netherlands
ID NLM: 9111860

Informations de publication

Date de publication:
11 Jan 2024
Historique:
received: 05 05 2023
revised: 21 12 2023
accepted: 07 01 2024
medline: 14 1 2024
pubmed: 14 1 2024
entrez: 13 1 2024
Statut: aheadofprint

Résumé

This study examines the potential of a novel photoactivatable ciprofloxacin to act against bacterial infections and microbiomes related to biliary diseases. Additionally, the treatment is evaluated combining the impact of bile acids and antibiotics on biofilms Here innovative strategies are evaluated to addressing the elusive bile duct microbiome resulting in biofilm-related infections linked to biliary catheters. The healthy biliary system is considered sterile, but in disease, bile microbiomes can occur, and these correlate with hepatobiliary diseases. Causes included biofilms that form on internal-external biliary drainage catheters. These biliary catheters can be used to study noninvasively the otherwise elusive bile microbiome for a pilot study. Here a new photoactivatable antibiotic was tested for efficacy against human-derived pathogenic bacterial isolates, Salmonella enterica and Escherichia coli, and catheter derived bile duct microbiomes. In addition, the effect of bile acids on antibiotic treatment of biofilms was quantified using crystal violet staining, confocal laser scanning microscopy, and biofilm image analysis. Two novel approaches for targeting biliary biofilms were tested. A photo-activated antibiotic based on ciprofloxacin showed efficacy in preventing biofilm formation and reducing bacterial viability without harming eukaryotic cells. Furthermore, a combinatorial treatment of antibiotics together with bile acids such as ursodesoxycholic acid (UDCA) only mildly influenced biofilm biomass but reduced bacterial survival within biofilms. Bile acids, in addition to their endocrine and paracrine functions, may enhance antibiotic killing of bacterial biofilms compared to antibiotics alone. These approaches hold promise for treating biliary infections such as cholangitis.

Identifiants

pubmed: 38218325
pii: S0924-8579(24)00004-9
doi: 10.1016/j.ijantimicag.2024.107086
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

107086

Informations de copyright

Copyright © 2024. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declaration of competing interest There are no conflicts of Interest for all authors.

Auteurs

Nino Eberhardt (N)

Institute for Organic and Macromolecular Chemistry, Friedrich-Schiller-University, Jena, Germany.

Belen Gonzalez Santamarina (BG)

Department of Anesthesiology and Intensive Care Medicine, University Hospital Jena, Germany; Leibniz Centre for Photonics in Infection Research (LPI), Friedrich Schiller University, Jena, Germany.

Marie-Luise Enghardt (ML)

Department of Anesthesiology and Intensive Care Medicine, University Hospital Jena, Germany; Theoretical Microbial Ecology, Friedrich Schiller University, Jena, Germany.

Oliver Rohland (O)

Department of General, Visceral and Vascular Surgery, University Hospital Jena, Germany.

Iqra Hussain (I)

Department of Anesthesiology and Intensive Care Medicine, University Hospital Jena, Germany.

Astrid Tannert (A)

Leibniz Institute of Photonic Technology, Jena, Germany; Integrated Research and Treatment Center, Center for Sepsis Control and Care, University Hospital Jena, Germany.

Lara Thieme (L)

Leibniz Centre for Photonics in Infection Research (LPI), Friedrich Schiller University, Jena, Germany; Jena University Hospital, Institute of Infectious Diseases and Infection Control, Friedrich-Schiller-University Jena, Am Klinikum 1, 07747 Jena, Germany.

Ignacio Rubio (I)

Department of Anesthesiology and Intensive Care Medicine, University Hospital Jena, Germany; Leibniz Centre for Photonics in Infection Research (LPI), Friedrich Schiller University, Jena, Germany; Integrated Research and Treatment Center, Center for Sepsis Control and Care, University Hospital Jena, Germany.

Jürgen Rödel (J)

Department of Medical Microbiology, Friedrich Schiller University, Jena, Germany.

Bettina Löffler (B)

Department of Medical Microbiology, Friedrich Schiller University, Jena, Germany.

Hans-Dieter Arndt (HD)

Institute for Organic and Macromolecular Chemistry, Friedrich-Schiller-University, Jena, Germany.

Michael Bauer (M)

Department of Anesthesiology and Intensive Care Medicine, University Hospital Jena, Germany; Leibniz Centre for Photonics in Infection Research (LPI), Friedrich Schiller University, Jena, Germany; Integrated Research and Treatment Center, Center for Sepsis Control and Care, University Hospital Jena, Germany.

Anne Busch (A)

Department of Anesthesiology and Intensive Care Medicine, University Hospital Jena, Germany; Theoretical Microbial Ecology, Friedrich Schiller University, Jena, Germany; Integrated Research and Treatment Center, Center for Sepsis Control and Care, University Hospital Jena, Germany. Electronic address: anne.busch@med.uni-jena.de.

Classifications MeSH